Hemodynamic, Oxygenation and Lymphocyte Parameters Predict COVID-19 Mortality.
Choirina WindradiTri Pudy AsmarawatiAlfian Nur RosyidErika MarfianiBagus Aulia MahdiOkla Sekar MartaniGiarena GiarenaEsthiningrum Dewi AgustinMilanitalia Gadys RosandyPublished in: Pathophysiology : the official journal of the International Society for Pathophysiology (2023)
The mortality of COVID-19 patients has left the world devastated. Many scoring systems have been developed to predict the mortality of COVID-19 patients, but several scoring components cannot be carried out in limited health facilities. Herein, the authors attempted to create a new and easy scoring system involving mean arterial pressure (MAP), PF Ratio, or SF ratio-respiration rate (SF Ratio-R), and lymphocyte absolute, which were abbreviated as MPL or MSLR functioning, as a predictive scoring system for mortality within 30 days for COVID-19 patients. Of 132 patients with COVID-19 hospitalized between March and November 2021, we followed up on 96 patients. We present bivariate and multivariate analyses as well as the area under the curve (AUC) and Kaplan-Meier charts. From 96 patients, we obtained an MPL score of 3 points: MAP < 75 mmHg, PF Ratio < 200, and lymphocyte absolute < 1500/µL, whereas the MSLR score was 6 points: MAP < 75 mmHg, SF Ratio < 200, lymphocyte absolute < 1500/µL, and respiration rate 24/min. The MPL cut-off point is 2, while the MSLR is 4. MPL and MSLR have the same sensitivity (79.1%) and specificity (75.5%). The AUC value of MPL vs. MSLR was 0.802 vs. 0.807. The MPL ≥ 2 and MSLR ≥ 4 revealed similar predictions for survival within 30 days ( p < 0.05). Conclusion: MPL and MSLR scores are potential predictors of mortality in COVID-19 patients within 30 days in a resource-limited country.
Keyphrases
- sars cov
- cardiovascular events
- end stage renal disease
- newly diagnosed
- ejection fraction
- risk factors
- chronic kidney disease
- peripheral blood
- coronavirus disease
- prognostic factors
- public health
- cardiovascular disease
- type diabetes
- coronary artery disease
- patient reported outcomes
- risk assessment
- patient reported
- respiratory syndrome coronavirus
- high density